Company attributes
Venture Capital Firm attributes
Other attributes
Frazier Healthcare Partners is a Seattle, Washington, United States based venture capital firm founded in 1991.
The firm prefers to invest in companies operating in the pharmaceutical, healthcare services, medical products and biotechnology sectors.
The notable investment portfolio of Frazier Healthcare Partners includes Arcutis Biotherapeutics, Imago BioSciences, Recida Therapeutics, Scout Bio, Sojournix, Tarsus Pharmaceuticals, etc.
As of February 2020, Frazier Healthcare Partners has made 162 investments and had 57 exits.
Frazier Healthcare Partner is a private equity firm in Seattle that prefers to invest in companies focusing on healthcare services, pharmaceutical services, medical products, and related sectors. Founded in 1991 in Seattle, Washington, the firm invests in debt financing. This firm usually invests in Series B, Series C, and Series A rounds. The notable investment portfolio of Frazier Healthcare Partner includes Passage Bio, EBR Systems, Chimerix, CVRx, and Phathom Pharmaceuticals. As of January 2020, Frazier Healthcare Partners has made 355 investments and 160 exits.
